# New test could flag which men need aggressive prostate cancer treatment and which don’t

- URL: https://talkfuse.com/story/new-test-could-flag-which-men-need-aggressive-prostate-cancer-treatment-and-which-dont/
- Published: 2026-10-26T21:06:25+00:00
- Updated: 2026-10-26T23:49:53+00:00
- Original publisher: Fox News (publisher lean: Far right)
- Original article: https://www.foxnews.com/health/new-test-flag-which-men-need-aggressive-prostate-cancer-treatment
- Topics: Health, Medicine, Mental Health, World

## Key points

- Decipher scores may help tailor prostate cancer treatment.
- High scores were linked to worse outcomes.
- More research is needed before routine use.

## Summary

Researchers at University College London say the Decipher genomic test may help identify men with high-risk, localised prostate cancer who are most likely to benefit from adding abiraterone, and those who may avoid its side effects. The findings could support more tailored treatment, but researchers say further validation is needed before the test guides routine decisions.

The analysis included test scores from more than 27,000 patients in real-world data and 401 men in the STAMPEDE trial. Higher Decipher scores were linked to worse outcomes and may indicate greater benefit from additional treatment; lower scores suggested intensive therapy may be unnecessary. Abiraterone previously halved the risk of death in men with high-risk, localised disease in the trial.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.